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a  b  s  t  r  a  c  t
Achyrocline  satureioides  (Lam.)  DC.  Asteraceae,  ‘marcela  del  campo’,  possess  several  pharmacological
properties.  Previously  we  reported  antiviral  activity  of  an  aqueous  extract  of A.  satureioides  against  an
alphavirus,  Western  Equine  Encephalitis  virus.  Alphaviruses  are  highly  virulent  pathogens  which  cause
encephalitis  in humans  and  equines.  There  are  no  effective  antiviral  to  treat  its infections.  The  aim  of
this  study  was  to evaluate  in vitro  cytotoxic  and  antiviral  activities  against  Western  Equine  Encephalitis
virus  of  ﬁve  water  extract  chromatographic  fractions  from  A. satureioides  and  identify  the  main  com-
pounds  of  the  bioactive  fraction.  Also,  it was  to  assess  in vivo cytogenotoxic  ability  of  the  active  fraction.
Cytotoxicity  studies  revealed  low  toxicity  of  the  most  of  fractions  in  Vero  and  in  equine  peripheral  blood
mononuclear  cells.  Antiviral  studies  showed  that  the water  crude extract  – Sephadex  LH 20  –  fraction  3
MeOH–H2O  (Fraction  3) was  active  against  Western  Equine  Encephalitis  virus  with Effective  Concentra-
tion  50%  =  5  g/ml.  Selectivity  Indices  were  126.0  on  Vero  and  133.6  on peripheral  blood  mononuclear
cells,  four  times  higher  than  aqueous  extract  selectivity  index.  Regarding  the  mechanism  of  action  we
demonstrated  that  F3 exerted  its action  in  intracellular  replication  stages.  Further,  fraction  3  showed
important  virucidal  action.  Fraction  3  contains,  in order  of  highest  to  lowest:  chlorogenic  acid,  luteolin,
5,7,8-trimethoxyﬂavone,  3-O-methylquercetin  and caffeic  acid.  Fraction  3 did not induce  in vivo  toxic
nor  mutagenic  effect.  Therefore,  it is safe  its  application  as antiviral  potential.  Further  studies  of  antiviral
activity  in  vivo  will  be developed  using  a  murine  model.
rasil
he  CC©  2016  Sociedade  B
access  article  under  t
ntroduction
Medicinal plants are a relevant source of biologically active sub-
tances. Achyrocline satureioides (Lam.) DC. is a medicinal plant
ommonly known as ‘marcela del campo’ which belongs to fam-
ly Asteraceae, is native to America and also grows up in Europe
nd Africa. This plant is widely used in folk medicine. It is pop-
larly consumed in infusion, decoction, macerated, and as syrup
García et al., 1990; Alonso Paz et al., 1992) for the treatment
∗ Corresponding author.
E-mail: csabini@exa.unrc.edu.ar (M.C. Sabini).
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102-695X/© 2016 Sociedade Brasileira de Farmacognosia. Published by Elsevier Edit
reativecommons.org/licenses/by-nc-nd/4.0/).eira  de Farmacognosia.  Published  by Elsevier  Editora  Ltda.  This  is  an open
 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
of digestive and respiratory problems, as well as for viral infec-
tions (Filot Da Silva and Langeloh, 1994; Instituto Nacional de
Investigacion Agropecuaria, 2004; Taylor, 2005). Several phar-
macological properties, such as anti-inﬂammatory, antioxidant,
hypocholestorolemic, immunomodulatory, antimicrobial, antitu-
moral and antiviral have been scientiﬁcally conﬁrmed (Ruffa et al.,
2002; Bettega et al., 2004; De Souza et al., 2007; Ferraro et al., 2008;
González and Marioli, 2010; Espin˜a et al., 2012; Barioni et al., 2013;
Casero et al., 2015). In previous studies we  demonstrated absence
of cytogenotoxicity in vitro and in vivo of cold aqueous extract of
A. satureoides at high concentrations (Sabini et al., 2013). In other
studies, we reported strong antiviral activity of this crude aque-
ous extract against Western Equine Encephalitis virus (Sabini et al.,
2012).
ora Ltda. This is an open access article under the CC BY-NC-ND license (http://
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Western Equine Encephalitis virus (WEEV) is a member of
lphaviruses (Togaviridae family), which are a group of enveloped
iruses with a positive sense, single-stranded RNA genome
Contigiani, 1996) which generates encephalitis in humans and
quines. The encephalitic alphaviruses also include Eastern and
enezuelan Equine Encephalitis viruses (EEEV and VEEV). This com-
lex of virus is arboviruses, arthropod-borne viruses, and they
ause febrile illness and encephalitis. They are also the most impor-
ant emerging pathogens and that have caused many epidemics
n recent decades (Weaver and Reisen, 2010). Alphaviruses infect
eurons resulting in CNS inﬂammation and neuronal destruction
Steele and Twenhafel, 2010). These highly virulent pathogens can
ause severe disease in humans with high lethality, as well as
ong-term neurological sequelae in most survivors (Raveh et al.,
013). In infants and children this disease is even more serious
nd is often associated with seizures (Grifﬁn, 2001). Moreover,
his illness has economic importance because it causes signiﬁ-
ant morbidity and mortality in humans and animals. Besides,
here are currently no effective antiviral drugs for alphavirus infec-
ions (Steiner et al., 2010). These viruses have been classiﬁed as
otential agents of biological weapons that could endanger public
afety (Zacks and Paessler, 2010). Therefore, it is a public health
riority to develop antiviral agents for treatment of alphaviruses
nfection.
On the other hand, it has been shown that several ﬂavonoids
nd phenolic acids have antiviral activity against viruses’ spectrum
Orhan et al., 2009; Andres et al., 2009; Ozc¸ elik et al., 2011; Ikeda
t al., 2011). Therefore, vegetal fractions rich in ﬂavonoids and
henolic acids obtained of A. satureioides could be active against
EEV.
The aim of the present study is to evaluate in vitro cytotoxic
bility and antiviral action of ﬁve water extract chromatographic
ractions obtained from A. satureioides against Western Equine
ncephalitis virus and identiﬁes the main compounds of the bioac-
ive fraction by HPLC–ESI-MS/MS. Other aim is to evaluate in vivo
ytogenotoxic ability of the active fraction, in order to consider
ts future application as antiviral in the treatment of viral diseases
aused by alphaviruses.
aterial and methods
lant material
Achyrocline satureioides (Lam.) D.C., Asteraceae, plants were col-
ected manually from Villa Jorcoricó, located in southern Córdoba
ills (32◦41′S; 64◦43′W;  800 m.a.s.l.) in March 2010. The plant
aterial was identiﬁed by Dr. Luis Del Vitto, Faculty of Pharmacy
nd Biochemistry, University of San Luis, San Luis, Argentina. A
oucher specimen was deposited in the herbarium of the University
f San Luis (no. 6362).
btention of water extract chromatographic fractions of
chyrocline satureioides
Aerial vegetal parts (leaves, stems and blooms) were mechan-
cally grinded using a knife mill (Retsch K.G. 5657Haan West-
ermany) with a mesh no. 5 (sieve opening 4 mm)  and were
ubmitted to extraction with cold water (4 ◦C) (15 g of dried and
ulverized material per 700 ml  of water) for 2 days. This suspension
as identiﬁed as cold aqueous extract (CAE). The suspension was
ltered and lyophilized. The dried extract (1 g) was  resuspended in
ater and was submitted to fractionation on Sephadex LH20 col-
mn  (2.5 cm × 20 cm)  eluted successively with CH3OH (100%) to
H3OH:H2O (9:1). Five fractions were collected from CAE (fractions
–5), which were subjected to drying in rotary evaporator.rmacognosia 26 (2016) 571–578
Cell culture and virus
Bioassays were performed on Vero cells (ATCC CCL-81) grown
in Eagle’s minimal essential medium (MEM;  Gibco, USA) sup-
plemented with 10% (v/v) heat-inactivated fetal bovine serum
(FBS) (Natocor, Argentina), l-glutamine (30 g/ml) and gentami-
cin (50 g/ml) (both from Sigma–Aldrich, Italy). Cell cultures were
maintained at 37 ◦C with 5% CO2 in a humidiﬁed atmosphere.
WEEV strain Ag 80-646, an enzootic strain, was isolated in Chaco
(Argentina) from Culex (Melanoconion) ocossa mosquitoes (Mitchell
et al., 1985). The virus was  propagated by intracerebral inoculation
in infant Rockefeller mice. Viral stocks were stored at −70 ◦C.
Virus titration
Virus was  titrated by quantiﬁcation plaques-forming unit (PFU)
method for arbovirus (Early et al., 1967). Cell monolayers grown in
24-well culture plates (Cellstar, Greiner Bio-One, Germany) were
infected with 100 l of ten-fold serial dilutions of virus per well,
in duplicate and were incubated for 1 h at 37 ◦C. After that, resid-
ual virus was removed. Cells were washed with PBS, and overlaid
with MEM-0.5% UltraPure Agarose (Invitrogen, USA) and further
incubated for 96 h at 37 ◦C. After incubation, cell monolayers were
ﬁxed with 10% formalin (Cicarelli, Argentina) and further stained
with 1% crystal violet solution.
Cytotoxicity assays
Cytotoxicity on Vero cells
For cytotoxicity assays, the cells (2 × 105 cells/ml) were cul-
tured in 96-well culture plates. After incubation for 24 h at 37 ◦C,
cells were exposed to increasing concentrations of F1, F2, F4, F5
(0–200 g/ml) and F3 (0–1000 g/ml). Assays were carried out in
triplicate. Monolayers incubated only with maintenance medium
(MM:  MEM  with 2% of FBS) were used as controls of cellular via-
bility. The cytotoxic concentration of fraction which reduced the
viable cell number by 50% (CC50) was determined by neutral red
uptake (NRU) assay.
After treatment of cells with water extract chromatographic
fractions (Fs) for 96 h, the microplates were incubated with NR solu-
tion for 3 h at 37 ◦C and ﬁnally, with an extraction solution (49%
distilled water:50% ethanol:1% acetic acid) for 15 min  in a shaker.
The absorbance was read at 540 nm on a multiwell spectropho-
tometer (Bio-Tek, ELx800, USA) (Rajbhandari et al., 2001; Seth
et al., 2004). Percentage survival fraction was calculated consid-
ering optical density (OD) of treated cultures versus controls.
Isolation of equine peripheral blood mononuclear cells
Peripheral blood was drawn from healthy individuals. PBMC
(Peripheral Blood Mononuclear Cells) were isolated from blood
samples using Hystopaque-1077 centrifugation (Sigma–Aldrich, St.
Louis, USA). From an optimal suspension 1 × 106 cells/ml, cell via-
bility was determined by Trypan blue dye exclusion assay (Mongini
and Waldner, 1996). The study was  approved by the Comité de
Ética de la Investigación Cientíﬁca (COEDI) with number 73/2012,
Universidad Nacional de Río Cuarto.
Cytotoxicity on equine PBMC
The cells (2 × 105 cells/well) in 200 l of ﬁnal volume were
cultured in sterile 96-well microplates containing RPMI-1640
medium, added with 25 mM Hepes, 2 mM l-glutamine, 5%
FBS, 50 mM 2-mercaptoethanol, 100 g/ml streptomycin and
100 g/ml penicillin. Cells were exposed to different concentra-
tions of F1, F2, F4, F5 (0–200 g/ml) and F3 (0–500 g/ml). Cell
cultures with only RPMI-1640 were used as control. The system
was incubated at 37 ◦C with 5% CO2 and humidiﬁed atmosphere
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or 24 h. After that time, cell viability was evaluated by Trypan blue
ye exclusion using Neubauer chamber for counting of viable cells,
s described by Militao et al. (2006). Each experiment was done in
riplicate.
ntiviral activity
Monolayers grown in 24-well culture plates (Cellstar, Greiner
io-One, Germany) were exposed to 100 PFU of WEEV per well
or 1 h at 37 ◦C and treated with one concentration of each F: F1
50 g/ml), F2 (20 g/ml), F3 (50 g/ml), F4 (50 g/ml) and F5
50 g/ml). Cultures were washed and overlaid with MEM-0.5%
ltraPure Agarose (Invitrogen, USA) containing each F at the same
oncentration which in the adsorption and penetration and incu-
ated for 96 h at 37 ◦C. After incubation, cell monolayers were ﬁxed
ith 10% formalin (Cicarelli, Argentina) and then stained with 1%
rystal violet solution. Controls of virus, cells and F were included
n all assays. A positive antiviral control was not included because
here are no effective antiviral drugs against WEEV. The number of
laques of treated cells was compared to untreated viral controls
o calculate the plaque reduction percentage.
etermination of the mechanism of action of F3
In order to study the antiviral activity of the F3, three exper-
ments were performed by adding the fraction at different times
nd evaluating the inhibitory action by a plaque reduction assay.
dsorption and penetration
Monolayers grown in 24-well culture plates (Cellstar, Greiner
io-One, Germany) were exposed to 100 PFU of WEEV per well
or 1 h at 37 ◦C in the presence of 50 g/ml of F3. After adsorption,
esidual inoculum was removed, and MEM-0.5% agarose was added
nd incubated for 96 h at 37 ◦C. After incubation, cell monolayers
ere ﬁxed with 10% formalin and stained with 1% crystal violet
olution. Controls of virus, cells and F3 were included in all assays.
he number of plaques of treated cells was compared to untreated
iral controls to calculate the plaque reduction percentage.
ost-penetration
Cells were infected with 100 PFU of virus per well and incubated
or 1 h at 37 ◦C. Then any unadsorbed virus was removed. Cells were
ashed with PBS, and then MEM-0.5% agarose containing 50 g/ml
f F3 was added. After incubation, cell monolayers were ﬁxed with
0% formalin and stained with 1% crystal violet solution. Controls
f virus, cells and F3 were included in all assays. The number of
laques of treated cells was compared to untreated viral controls
o calculate the plaque reduction percentage.
irucidal activity
To determine the ability of F3 to inactivate directly the virus par-
icles, equal volumes of WEEV (200 PFU/100 l) and F3 (50 g/ml)
ere mixed and incubated for 1 h at 37 ◦C. Afterwards, each mixture
as added to cultures (100 l per well). It was incubated for 1 h at
7 ◦C. Then, monolayers were washed and covered with MEM-0.5%
garose. Controls of virus, cells and F3 were included. After incuba-
ion for four days at 37 ◦C, the cells were ﬁxed with 10% formalin
nd stained with 1% crystal violet solution. The plaque reduction
ercentage was calculated.
etermination of 50% effective concentration (EC50)Cell monolayers cultured in 24-well microplates were infected
ith 100 PFU per well, and incubated for 1 h at 37 ◦C. Residual
noculum was removed; cells were washed with PBS and MEM-
.5% agarose containing increasing concentrations of F3 was added.rmacognosia 26 (2016) 571–578 573
After four days at 37 ◦C, the cultures were ﬁxed; stained and viral
plaques were counted. The EC50 was calculated as the F concentra-
tion that reduced the number of PFU to 50% with respect to viral
control. EC50 and CC50 values were estimated by non-linear regres-
sion of concentration–response curves generated from the data.
Cytotoxicity and antiviral activity results were used to calculate
the Selectivity Index (SI) of F3 (SI = CC50/EC50).
Genotoxicity assays
Animals and treatment
Male and female Balb/c mice aged 8–12-weeks old, (weighing
20–25 g) were obtained from the Central Bioterio of the Univer-
sidad Nacional de Río Cuarto. Animals had access to food and
water ad libitum and were housed in a temperature controlled
environment on a 12 h light/12 h dark cycle throughout the exper-
imental period. All experimental procedures were conducted in
accordance with recent legislation. This study was  approved with
number 73/2012 by Comité de Ética de la Investigación Cientí-
ﬁca (COEDI), Universidad Nacional de Río Cuarto. Three groups
of mice were inoculated by intraperitoneal injection with F3
at concentrations of 3, 6 and 12 mg/kg body weight (b.w.) dis-
solved in saline solution and 2 control groups were included.
The negative control group received saline solution and the pos-
itive control group received 30 mg/kg b.w. of cyclophosphamide
(Sigma–Aldrich, St. Louis, US). Each treatment group consisted of
four animals.
Micronuclei test in mouse bone marrow. The assay was  carried
out following standard protocols as recommended by Schmid
(1975). The animals were sacriﬁced by cervical dislocation
at 24 h post-injection. The bone marrow samples of femoral
bone were obtained with FBS, were homogenized, centrifuged,
and plated on slides which were ﬁxed by soft ﬂutter. Then,
the slides were stained with May-Grunwald–Giemsa. To estab-
lish genotoxic capacity of F3, the frequency of micronuclei
in 1000 polychromatic erythrocytes per slide was  determined.
To detect possible cytotoxic effects, the ratio of polychromatic
erythrocyte/normochromatic erythrocyte (PCE/NCE) in 1000 poly-
chromatic erythrocyte was  calculated. The slides were scored
using a light microscope at a 1000× magniﬁcation. Average num-
ber of micronucleated polychromatic erythrocytes (MNPCE) in
individual mice was used as the experimental unit, with vari-
ability based on differences among animals within the same
group.
Single-cell gel electrophoresis (comet assay). After 24 h of treatment
with F3, peripheral blood was drawn from the tail vein of mice
in heparinized tubes to perform the comet assay. Comet assay (CA)
was carried out following a method described by Singh et al. (1988)
with slight modiﬁcations. All determinations were performed by
quadruplicate. A 50 l aliquot of blood was mixed with 100 l
0.75% low melting point agarose at 37 ◦C. Immediately 75 l  was
spread onto two  microscope slides per concentration pre-coated
with 0.75% normal melting point agarose. The slides were cover-
slipped and allowed to gel at 4 ◦C for 20 min. The coverslips were
gently removed and 75 l of 0.75% low melting point agarose at
37 ◦C was added. Again, the slides were coverslipped and allowed
to gel at 4 ◦C for 20 min. The coverslips were removed and the
slides were immersed in cold, freshly prepared lysing solution
(2.5 M NaCl, 100 mM EDTA, 10 mM Tris (pH 10), supplemented with
1% Triton X-100 and 10% DMSO (Merck)). The slides, which were
protected from light, were allowed to stand at 4 ◦C for 1 h. They
were placed in a gel box, and left in high pH (>13) electrophoresis
buffer (300 mM NaOH, 1 mM EDTA, prepared from a stock solu-
tion of 10 N NaOH and 200 mM EDTA) at 4 ◦C for 20 min before
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treated during adsorption and penetration and post-adsorption and
penetration in separate trials. WEEV was  not inhibited in adsorp-
tion and penetration stages, indicating 15% of inhibition. While it
was inhibited in 100% when it was treated post-adsorption and
Table 1
Cytotoxicity of F1, F2, F3, F4 and F5 of Achyrocline satureioides on Vero cells and
equine PBMCs determined by neutral red uptake (NRU) and trypan blue exclusion
(TB) assays, respectively.
Fraction Cytotoxicity
Vero cells by NRU
(CC50 g/ml)
Equine PBMCs by TB
(CC50 g/ml)
F1 >200 >20074 M.C. Sabini et al. / Revista Brasileir
lectrophoresis to allow the DNA to unwind. Electrophoresis was
arried out in ice bath (4 ◦C) for 20 min  at 250 mA  and 30 V
0.722 V/cm). The slides were submerged in neutralization buffer
0.4 M Tris–HCl, pH 7.5) for 15 min, dried at room temperature
nd ﬁxed in absolute ethanol for 10 min. The slides were dried
nd stored overnight or longer before staining. For staining the
lides were brieﬂy rinsed in distilled water, covered with 25 l
× ethidium bromide staining solution prepared from a 200 g/ml
0× stock solution, and coverslipped. The material was  evaluated
mmediately at 400× magniﬁcation using ﬂuorescence microscope
Axiophot, Carl Zeiss, Germany) attached to the image-analysis sys-
em (Powershot G6, 7.1 megapixels, Canon INC, Japan with software
xioVision Release 4.6.3, Carl Zeiss, Germany), with 515–560 nm
xcitation ﬁlter and a 590 nm barrier ﬁlter. From each treatment,
mages from 100 “nucleoids” were captured with a camera attached
o the ﬂuorescent microscope and linked to the CometScore® 1.5
oftware. Highly damaged cells were not included in the scoring
clouds were not analyzed). Tail moment (TM) was used to estimate
NA damage (arbitrary units).
tatistical analysis
Statistical analysis was performed using GraphPad Prism pro-
ram, version 5.00.288 (San Diego, USA, 2007). The CC50 and
C50 were calculated from concentration–effect plots by non-linear
egression analysis (Boltzmann sigmoidal). The results account for
he mean ± standard error of the mean values of three differ-
nt experiments. Results obtained by micronucleus assays were
ubmitted to a oneway analysis of variance (ANOVA) and the
ukey’s multiple comparison test. Comet assay results were sub-
itted to Kruskal Wallis test and Dunns multiple comparison as
 posteriori test were used in all the experiments. The Spear-
an statistical test was used to examine possible dose–response
ffects. In all cases, the level of signiﬁcance was  established at
 < 0.001.
dentiﬁcation and quantiﬁcation of polyphenol and ﬂavonoid
erivatives in F3 by HPLC–ESI-MS/MS
ample preparation
A solution of F3 (2.25 mg/ml) was prepared to carry out its qual-
tative and quantitative analysis by HPLC–ESI-MS/MS. MeOH–HPLC
rade (Merck) was used in all samples, which were ﬁltered through
 Millipore membrane (0.45 m)  before HPLC analysis.
PLC–ESI-MS/MS instruments and chromatographic conditions
An Agilent Series 1200 LC System (Agilent, USA) coupled to a
icrOTOF Q II (Bruker Daltonics, USA) was used for HPLC–ESI-
S/MS  analysis. The HPLC system consisted in a micro vacuum
egasser, binary pumps, an autosampler (40 l sample loop), a
hermostated column compartment, and a diode array detector.
he mass spectrometer equipped with electrospray ion source and
TOF analyzer, was used in MS  and MS/MS  mode for the structural
nalysis of phenolics and ﬂavonoids.
HPLC analysis were performed on a thermostated (40 ◦C) Hyper-
il 5 column C18 (30 × 4.6 mm,  Phenomenex) at a 0.4 ml/min ﬂow
ate using MeOH–formic acid 0.16 M (53:47) as mobile phase (De
ouza et al., 2002). The injection volume was 40 l.
ESI-MS detection was performed in negative ion mode with
ass acquisition between 100 and 1500 Da. Nitrogen was  used as
rying and nebulizer gas (7 l/min and 3.5 bar, respectively), and
80 ◦C for drying temperature. For MS/MS  experiments fragmen-
ation was achieved by using Auto MS2 option. DAD analyses were
arried out in the range between 200 and 700 nm.
Calibration standard samples were prepared by appropriate
ilutions with MeOH from the stock solutions and ﬁltered onrmacognosia 26 (2016) 571–578
Millipore membrane before use. MS  analysis was used for quan-
tiﬁcation of the compounds with speciﬁc calibration curve. When
reference compounds were not available, the calibration of struc-
turally related substance was used. Compounds concentrations
were calculated in triplicate and reported as means ± standard
deviation in each case.
Results
Obtention of water extract chromatographic fractions of
Achyrocline satureioides
Five water extract chromatographic fractions were obtained
from CAE of A. satureioides. After drying them, 202.4 mg  of F1,
68.6 mg  of F2, 39.9 mg  of F3, 48.6 mg  of F4 and 277.3 mg  of F5 were
obtained. It indicated a yield of 20.24%, 6.86%, 3.99%, 4.86% and
27.73% for F1, F2, F3, F4 and F5, respectively.
Cytotoxicity assays
First, ﬁve water extract chromatographic fractions of A. sat-
ureioides were evaluated in their cytotoxic capacity for then to
evaluate of their antiviral action. Cytotoxicity on Vero cells was
determined by neutral red uptake (NRU) assay and, equine PBMC
viability was  determined by trypan blue dye exclusion method
(TB). Cytotoxic concentrations 50% (CC50) of water extract chro-
matographic fractions are presented in Table 1. F1, F4 and F5
indicated CC50 values above 200 g/ml in both type of cells. The
viability percent at 200 g/ml was greater than 80% for these frac-
tions. F2 was  the most toxic on Vero cells with CC50 value of
35 g/ml. However, it was  not toxic in equine PBMCs whose CC50
was higher than 200 g/ml. On the other hand, F3 indicated CC50
values of 630 g/ml on Vero cells and 668 g/ml on equine PBMC
(Figs. 1 and 2). The effect of F3 on viability of Vero cells and equine
PBMCs showed a dose-dependent decrease in the number of viable
cells.
Antiviral activity of ﬁve water extract chromatographic fractions
Antiviral studies indicated that F1, F2 and F4 did not inhibit to
WEEV. The percent of inhibition were lower than 30%. While, F5
and F3 indicated 45% and 100% of inhibition, respectively (Fig. 3).
F3 was  the most effective against WEEV. Thus, it was submitted at
antiviral mechanism studies.
Determination of the mechanism of action of F3
To elucidate the mechanism of action of F3, WEEV wasF2 35 >200
F3 630 668
F4  >200 >200
F5 >200 >200
M.C. Sabini et al. / Revista Brasileira de Farmacognosia 26 (2016) 571–578 575
120
100
80
60
40
20
0
Vi
ab
ilit
y, 
%
0 200 400
CC50=630 µg/ml
600
Concentration (µg/ml)
800 1000 1200
Fig. 1. Viability of Vero cells exposed to different concentrations of fraction 3
(F3) of Achyrocline satureioides for 96 h. The results are presented as percentage
(mean ± SD). Cell viability was  evaluated by neutral red uptake (NRU) assay.
120
100
80
60
40
20
0
0 200 400 600 800 1000 1200
Vi
ab
ilit
y, 
%
CC50=668 µg/ml
Concentration (µg/ml)
Fig. 2. Viability of equine PBMCs from healthy individuals exposed to different con-
centrations of fraction 3 (F3) of Achyrocline satureioides for 24 h. The results are
presented as percentage (mean ± SD). Cell viability was evaluated by trypan blue
dye  exclusion (TB) method.
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Fig. 3. Percent of inhibition of Western Equine Encephalitis virus (Ag 80-646) treated
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Fig. 4. Determination of effective concentration 50% (EC50) of F3 of Achyrocline sat-
ureioides against Western Equine Encephalitis Virus. Note: Vero cell monolayers were
infected with about 100 PFU per well, and incubated for 1 h at 37 ◦C. MEM-0.5%
agarose with increasing concentrations (5–100 g/ml) of F3 was added. After incu-
bation for four days at 37 ◦C, viral plaques were counted. Thereafter the percentage
The chemical evaluation of F3 obtained from A. satureioides,
was oriented toward the search for the active principles reportedith ﬁve water extract chromatographic fractions obtained from Achyrocline sat-
reioides.
enetration with 50 g/ml of F3. Therefore, the fraction exerts its
ioactivity in stages intracellular of the replication. Moreover, the
irucidal action indicated a signiﬁcant inactivation (60%) of WEEV
hen it was treated with 50 g/ml of F3.inhibition was calculated, and the EC50 was determined. Data account for the means
of  three separate experiments.
Determination of 50% effective concentration (EC50)
Cell cultures treated with concentrations from 5 to 100 g/ml of
F3 was used to construct the dose–response curve which allowed
to determine the EC50 value, see Fig. 4.
Table 2 summarizes the results of EC50, CC50 and Selectivity
Indices (SI) determined on Vero cells and equine lymphocytes.
These values (SI) were 126.0 and 133.6 on Vero and PBMC, respec-
tively. The SI of F3 is four times higher than the SI of cold aqueous
extract (CAE) of A. satureioides which was 32 by NRU.
Genotoxicity assays
Micronuclei test in mouse bone marrow
The results of cytogenotoxic ability of F3 are shown in Table 3.
In this study, the negative control group demonstrated low MNPCE
values, as expected, and the positive control group’s MNPCE
frequency was signiﬁcantly higher (p < 0.001), conﬁrming the sen-
sitivity of the test. The F3 genotoxicity analysis, for all doses tested
(3, 6, and 12 mg/kg b.w.), indicated no signiﬁcant increase in the
MNPCE frequency at 24 h when compared with the negative control
group (p < 0.001). The positive control which indicated a genotox-
icity index of 31.75 (±2.21) showed signiﬁcant difference with all
treatments (p < 0.001).
Regarding F3 toxicity, statistical analysis of the PCE/NCE ratio
revealed no signiﬁcant differences between any of the treatments
versus the negative control. Therefore, F3 of A. satureioides does not
have cytogenotoxic effects.
Single-cell gel electrophoresis (comet assay)
The results of comet assay analyzed in mice’s blood are shown
in Fig. 5. Based on the tail moment results, positive control revealed
signiﬁcant difference with negative control (p < 0.001). All the treat-
ments with F3 of A. satureioides did not show signiﬁcant difference
with negative control group while it did show statistically signiﬁ-
cant difference with mitomycin C (positive control group).
HPLC–ESI-MS/MS analysis of fraction 3 (F3) of A. satureioidespreviously in the vegetal species (De Souza et al., 2002; Polydoro
et al., 2004; Retta et al., 2012). By means of the qualitative
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Table 2
Selectivity indices of F3 of Achyrocline satureioides against WEEV.
Fraction CC50 (g/ml) EC50 (g/ml) SI (CC50/EC50)
Vero cells Equine PBMCs against WEEV Vero cells Equine PBMCs
F3 630 668 5 126.0 133.6
Table 3
Frequency of micronucleated polychromatic erythrocytes (MNPCE) and polychromatic erythrocytes/normochromatic erythrocytes (PCE/NCE) ratio (TI) in mice bone marrow
cells  treated with different doses of F3 of Achyrocline satureioides for 24 h, and respective controls.
Treatments Dose (mg/kg) MNPCE (‰)
(mean ± SD)
PCE/NCE (TI)
(mean ± SD)
Total Total
Negative control (saline solution) 0 7.00 ( ± 0.70) 1.83 ( ± 0.41)
A.  satureioides F3 3 7.25 ( ± 0.95) 1.79 ( ± 0.09)
A.  satureioides F3 6 7.60 ( ± 1.34) 1.71 ( ± 0.19)
A.  satureioides F3 12 6.50 ( ± 1.76) 1.64 ( ± 0.34)
Positive control (cyclophosphamide) 30 31.75 ( ± 2.21)a 1.61 ( ± 0.12)
SD, standard deviation; MNPCE, micronucleated polychromatic erythrocytes; PCE, polychromatic erythrocytes; NCE, normochromatic erythrocytes; TI, Toxicity Index. In all
cases  2000 polychromatic erythrocytes (PCE) were analyzed.
a Signiﬁcantly different from negative control (p < 0.001) (ANOVA Tukey test).
Table 4
Chemical composition of F3 of Achyrocline satureioides.
Compound Parent ion [M−1]− m/z  tR (min) % P/P (mg  compound/100 mg F3)
Chlorogenic acid 353 6.8 1.360 ± 0.008
Caffeic acida 179 6.3 0.004 ± 0.001
3-O-Methylquercetinb 315 22.3 0.009 ± 0.002
Quercetin-3-metoxi 331 5.1 nc
5,7,8-Trimethoxyﬂavoneb 311 6.6 0.018 ± 0.002
Luteolin 285 21.9 0.537 ± 0.010
a 3-O-methylquercetin and 5,7,8-trimethoxyﬂavone expressed in quercetin.
b Caffeic acid expressed in chlorogenic acid.
nc  = Is below the detection limit.
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Fig. 5. Comet assay in blood of Balb/c mice inoculated with 3, 6 and 12 mg/kg b.w.
of  F3 of Achyrocline satureioides. Results are expressed as tail moment. Data shown
a
H
d
e
(
d
t
m
we were able to demonstrate the ability of an aqueous extract of
A. satureioides to inhibit at WEE  virus with a great selectivity indexre means of four replicate cells samples (p < 0.001; Dunns test).
PLC-ESI-MS analysis, we were able to identify the presence of
ifferent ﬂavonoids and organic acids (Table 4). The amount of
ach compound in the fraction under study is showed in Table 4
quantiﬁcation analysis). Data are expressed as means ± standard
eviation (SD) of three separate experiments.
The components detected in the sample were, in order of highest
o lowest: chlorogenic acid, luteolin, 5,7,8-trimethoxyﬂavone, 3-O-
ethylquercetin and caffeic acid.Discussion
Medicinal plants are a rich source of molecules that may  exert
different bioactivities. Considering that there is no effective antivi-
ral to treat diseases caused by alphavirus and, moreover, the
disadvantages of use synthetic drugs, is very relevant to study
medicinal plants as a possible solution to solve this problem.
Cytotoxicity studies revealed that the majority of fractions of A.
satureioides had low toxicity in both type of cells. F1, F4 and F5 indi-
cated viability percents greater than 80% at 200 g/ml. F2 showed
higher cytotoxic capacity against Vero cells (CC50 = 35 g/ml) than
against equine lymphocytes (CC50 > 200 g/ml). Probably, the com-
pounds present in F2 do not affect the integrity of the membranes
of lymphocytes at concentrations that generate lysosomal damage
in Vero cells.
Given that F3 was active against WEEV its cytotoxic potential
was studied at higher concentrations. F3 showed CC50 values of
630 and 668 g/ml on Vero cells and on equine PBMC, respec-
tively. Moreover, the evaluation of F3 against equine lymphocytes
allows us to express that this fraction at high concentrations did not
affect this type of cells of immune system. This is very important
because leucopenia occurs during viremia period of WEEV (Peters
and Dalrymple, 1990).
There are few researches which evaluate the antiviral action
against alphaviruses and, in particular, against WEEV (Madsen et al.,
2014; Raveh et al., 2013; Sindac et al., 2013). There are no antiviral
studies employing medicinal plants. However, in a previous paper,(SI = 32) (Sabini et al., 2012). In the present study, we demonstrated
that fraction 3 showed to be more potent than the aqueous extract
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gainst this alphavirus. Its SI was four times higher than the SI of
queous extract. This indicates which fraction could be better for
reating alphavirus infections.
Moreover, the SI of F3 was higher (126.0 and 133.6) than
he SI of synthetic compounds such as third generation indole-2-
arboxamide derivatives whose SI were at or below 14 (Sindac et al.,
013). These results support the use of natural products for treating
iseases of viral etiology.
Respect to the mechanism of action, the fraction exerted its
ioactivity in stages intracellular of the replication. Further, F3
howed an important virucidal action.
The chemical studies indicated that F3 contains, in order of high-
st to lowest: chlorogenic acid, luteolin, 5,7,8-trimethoxyﬂavone,
-O-methylquercetin and caffeic acid. The present study showed
hat the fraction rich in chlorogenic acid and luteolin (F3) has
trong inhibitory activity against Western Equine Encephalitis
irus.
Some investigations reported antiviral action of the compounds
resent in F3. However, there is no background about antiviral
apacity against WEEV or alphavirus. Thus, Xu et al., 2014 reported
he antiviral ability of luteolin against other viruses, Enterovirus 71
nd Coxsackievirus A16. In other research it was demonstrated the
nhibition of replication of Enterovirus 71 by chlorogenic acid (Li
t al., 2013).
Other researchers reported that herpes simplex virus was
nhibited by caffeic acid (Ikeda et al., 2011). Also, caffeic acid
nhibited the inﬂuenza A virus multiplication in vitro (Utsunomiya
t al., 2014). Although caffeic acid is in low proportion in F3 it could
e the responsible compound of its bioactivity against WEEV.
Also, it has been demonstrated antiviral capacity 3-O-
ethylquercetin, which was shown to be a potent inhibitor of
oliovirus RNA synthesis (Castrillo et al., 1986). Maybe, the com-
ounds present in F3 act alone or in a synergistic combination
gainst WEEV.
On the other hand, the results of genotoxic assessments of F3
f A. satureioides by MN (mononucleous) test showed no signiﬁ-
ant increase the MNPCE frequency at all doses tested (3, 6, and,
2 mg/kg) at 24 h nor exhibited toxic activity by analysis of the
CE/NCE ratio in mouse bone marrow cells. Additionally, the comet
ssay analyzed in mice’s blood indicated absence of genotoxicity
n all treatments of F3. Therefore, in the present work, the in vivo
tudies indicated that F3 of A. satureioides by both tests of cytogeno-
oxicity was neither toxic nor genotoxic, and the obtained results
upport the application of this fraction such as antiviral drug with
ecurity. Further relevant studies of antiviral activity in vivo will be
eveloped using a murine model.
In conclusion, F3 of Achyrocline satureioides showed low cyto-
oxicity in vitro in Vero and in equine lymphocytes cells. It showed
reat antiviral action in vitro against Western Equine Encephalitis
irus and it could be used as neurotropic alphaviruses inhibitor.
urthermore, the fraction at concentrations tested did not induce
n vivo toxic nor mutagenic effects. Therefore, its safe its application
s antiviral potential.
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